POINT BIOPHARMA GLOBAL INC

CUSIP: 730541109 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 213,865 Value ($000) $1,426 Avg Close — Range —
Q2 2023
Shares 270,278 Value ($000) $2,449 Avg Close — Range —
Q1 2023
Shares 66,657 Value ($000) $485 Avg Close — Range —